Point-of-Care Diagnostics Market: Rising Prevalence of Hepatitis is Driving the Market Growth

DataM Intelligence 12 Jun, 2019
Berlin, Germany

The market report titled ‘Global Point of Care Diagnostics Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.

GlobalPoint-of-Care Diagnostics Market Drivers and Restraints
The rising prevalence of hepatitis is one of the factors fueling the global point-of-care diagnostics market. According to the World Health Organization (WHO), hepatitis (especially hepatitis B and hepatitis C) was responsible for 1.34 million deaths in 2015 globally. Hepatitis A was the cause of death for 11,000 people in 2015.
According to the World Health Organization (WHO), 240 million people are infected with the hepatitis B virus worldwide, with 786,000 people dying from complications of the disease each year.
According to the World Health Organization (WHO), 71 million people are infected with hepatitis C worldwide, and the disease contributes to 399,000 deaths worldwide each year.

To Get a free sample of the report - https://www.datamintelligence.com/research-report/point-of-care-diagnostics-market

Global Point-of-Care Diagnostics Market Segmentation Analysis
Global point-of-care diagnostics market is segmented by product type, by platform, and by end users. The product type includes glucose monitoring products, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, tumour/cancer marker testing products, urinalysis testing products, cholesterol testing products, haematology testing products, drugs-of-abuse testing products, fecal occult testing products, and other POC products
Infectious disease testing products segment dominate the global point-of-care diagnostics market during the forecast period, due to the launch of new point-of-care diagnostics for infectious disease, and strategic collaboration between companies to develop new point-of-care diagnostics for infectious disease.

Global Point-of-Care Diagnostics Regional Analysis
The global point-of-care diagnostics market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
North America dominates the global point-of-care diagnostics market due to the increasing regulatory approval for point-of-care diagnostics.
In February 2018, Mesa Biotech Inc., have received 510(k) clearance from the US Food and Drug Administration (FDA) for point-of-care (POC) Accula Flu A/Flu B test, it is the first available test in the US market.
In February 2018, Siemens Healthineers has received 510(k) clearance from the U.S. Food and Drug Administration for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.

Global Point-of-Care Diagnostics Company Trends
Major market players in the Point-of-Care Diagnostics market are Abbott Laboratories, Becton, Dickinson, and Company (BD), Chembio Diagnostics, Johnson & Johnson, Nova Biomedical, Roche Diagnostics, Siemens Healthineers, Quidel Corporation, Instrumentation Laboratory, and EKF Diagnostics.
In February 2019, CENTOGENE have collaborated with Sarepta Therapeutics, Inc for a 12-month, for the identification of patients with Duchenne muscular dystrophy (DMD) in the Middle East and North Africa. CENTOGENE will perform complete molecular diagnostic testing using deletion/duplication analysis and full-length sequencing of the DMD gene in MLPA negative patients. Under the terms of the agreement with Sarepta, CENTOGENE will also provide diagnostic services to physicians treating patients exhibiting symptoms related to DMD.

Read more information about the report - https://www.datamintelligence.com/research-report/point-of-care-diagnostics-market

Table of contents overview -
1. Global Point-of-Care Diagnostics Market - Scope and methodology
2. Global Point-of-Care Diagnostics Market – Executive summary
3. Global Point-of-Care Diagnostics Market - Industry Analysis
4. Global Point-of-Care Diagnostics - Market Segmentation
4.1. BY product type
4.2. BY Platform
4.3. BY END USERS
5. Global Point-of-Care Diagnostics Market – By geography
6. Competitive Landscape
7. Company Profiles
8. Key companies to watch
9. Emerging Companies
10. Appendix

1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.

This release was published on openPR.